Naturalpha Report issue

For profit Phase 2
Founded: Loos France (2001)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2011
NCT01474161
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

gft505 (2 trials)

Drugs in Other Trials (3)

astaxanthin (1 trial)

cashew apple extract (1 trial)

cinnamon extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 1)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

Dyslipidemias (Phase 1)

Fatty Liver (Phase 2)

Metabolic Diseases (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 4